Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments

55Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

The effects of Fab fragments of high-affinity specific antibodies have been studied in a canine experimental model of lethal digitoxin toxicity. Selected antiserum from sheep immunized and boosted with a digoxin-serum albumin conjugate contained antibodies that cross-reacted with digitoxin with an average intrinsic association constant of 1.4 x 1010 M-1 as determined by equilibrium dialysis. Rapid second-order association kinetics (k(f) = 3.7 x 106 M-1 per s) and slow dissociation kinetics (k(r) = 1.9 x 10-4 per s) were documented for the antibody-digitoxin complex. Eight dogs given 0.5 mg/kg digitoxin intravenously developed ventricular tachycardia after 23 ± 4 (SEM) min. Control nonspecific Fab fragments were then given. All animals died an average of 101 ± 36 min after digitoxin administration. Another eight dogs given the same digitoxin dose similarly developed ventricular tachycardia after 28 ± 3 min. This group then received a molar equivalent dose of specific Fab fragments intravenously over 3 min, followed by a 30-min infusion of one-third of the initial dose. All dogs survived. Conducted sinus beats reappeared 18 ± 4 min after initial Fab infusion, and stable normal sinus rhythm was present at 54 ± 16 min. Plasma total digitoxin concentrations increased threefold during the hour after initial Fab infusion, while plasma free digitoxin concentration decreased to less than 0.1 ng/ml. Effects on digitoxin pharmacokinetics of these Fab fragments and the antibody population from which they were derived were further investigated in a primate species. Unlike common laboratory animals previously studied, the rhesus monkey was found to have a prolonged elimination half-life, estimated at 135 and 118 h by radioimmunoassay and [3H]digitoxin measurements, respectively, similar to man and thus providing a clinically relevant experimental model. Intravenous administration of 2 mol of specific Fab fragments per mole of digitoxin 6 h after 0.2 mg of digitoxin produced a rapid 4.3-fold increase in plasma total digitoxin concentration followed by a rapid fall (t(1/2) 4 h) accompanied by a 14-fold enhancement of urinary digitoxin excretion over control values during the 6-h period after Fab was given.

Cite

CITATION STYLE

APA

Ochs, H. R., & Smith, T. W. (1977). Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments. Journal of Clinical Investigation, 60(6), 1303–1313. https://doi.org/10.1172/JCI108889

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free